GGrantIndex
Sort

21,281 grants matching influenza

Software Development & Core Facilities

$193,878
Alessandro Vespignani · Fred Hutchinson Cancer Research Center · U54 · FY2015 · GM

Innate Control of Adaptive Immunity to SARS-CoV-2

$193,860
Benjamin Goldman-Israelow · Yale University · K08 · FY2025 · AI

Universal epitopes-based recombinant influenza vaccines

$193,854
Sang-Moo Kang · Georgia State University · R21 · FY2020 · AI

Innate Control of Adaptive Immunity to SARS-CoV-2

$193,828
Benjamin Goldman-Israelow · Yale University · K08 · FY2024 · AI

Innate Control of Adaptive Immunity to SARS-CoV-2

$193,764
Benjamin Goldman-Israelow · Yale University · K08 · FY2023 · AI

Community Engagement Core (CEC)

$193,751
Carla D Williams · Howard University · U54 · FY2021 · MD

Howard University Research Center for Minority Health and Health Disparities

$193,751
William M Southerland · Howard University · U54 · FY2021 · MD

Influenza PDZ Ligand Directed Pathogenesis

$193,750
Erich R. Mackow · State University New York Stony Brook · R21 · FY2007 · AI

Determining the mechanisms by which YesMN drives pneumococcal host-to-host transmission

$193,750
Muhammad Ammar Zafar · Wake Forest University Health Sciences · R21 · FY2021 · AI

CYTOKINE CONTROL OF RESPIRATORY IMMUNITY

$193,750
Albany Medical College · R01 · FY2001 · HL

The IRF-type I interferon system during gestation

$193,750
Michael David · University Of California, San Diego · R21 · FY2017 · AI

Attenuated Strains of Human Metapneumovirus for Vaccines and Pathogenesis

$193,750
John V Williams · Vanderbilt University · R21 · FY2010 · AI

Effectiveness of R848 conjugated IPR8 as a vaccine for the elderly

$193,750
Martha A. Alexander-Miller · Wake Forest University Health Sciences · R21 · FY2020 · AI

Unanchored Polyubiquitin Chains and Innate Immunity to Influenza Virus

$193,750
Ricardo Rajsbaum · University Of Texas Med Br Galveston · R21 · FY2017 · AI

The impact of aging and thymus regeneration on tissue-resident CD8 T cell responses to viral lung infection and vaccination

$193,750
Ann Venables Griffith · University Of Texas Hlth Science Center · R21 · FY2023 · AI

Studies of the global translational response to human virus infection

$193,750
John S Parker · Cornell University · R21 · FY2015 · AI

Animal models of SARS-CoV-2 bacterial Coinfection

$193,750
Yan Xiang · University Of Texas Hlth Science Center · R21 · FY2023 · AI

CYTOKINE CONTROL OF RESPIRATORY IMMUNITY

$193,750
Albany Medical College · R01 · FY2000 · HL

Obesity, Toll-Like Receptors, and Human Sensitivity to the Environment

$193,750
Kristen Mary Chossek Malecki · University Of Wisconsin-Madison · R21 · FY2020 · AI

Viral Vectored COVID-19 Vaccines in a Guinea Pig Perinatal Infection Model

$193,750
Mark R. Schleiss · University Of Minnesota · R21 · FY2022 · AI

Innate Control of Adaptive Immunity to SARS-CoV-2

$193,716
Benjamin Goldman-Israelow · Yale University · K08 · FY2021 · AI

Structural Basis for T Cell Recognition of SARS-CoV-2

$193,671
Roy A Mariuzza · Univ Of Maryland, College Park · R21 · FY2024 · AI

Biology of Influenza Virus Transmission

$193,652
Mila Brum Ortigoza · New York University School Of Medicine · K08 · FY2019 · AI

Elucidating the impact of immune imprinting on SARS-CoV-2 variant vaccination strategies using a humanized mouse model

$193,644
Anthony Bowen · Columbia University Health Sciences · K08 · FY2025 · AI

Elucidating the impact of immune imprinting on SARS-CoV-2 variant vaccination strategies using a humanized mouse model

$193,644
Anthony Bowen · Columbia University Health Sciences · K08 · FY2024 · AI